Not applicableStudy completedNCT01581528What this trial is testingStudying Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 15
Not applicableStudy completedNCT00712556What this trial is testingPET Study in Patients With Non-Hodgkin LymphomaWho this might be right forLymphoma Vanderbilt-Ingram Cancer Center 55
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Early research (Phase 1)Study completedNCT00003970What this trial is testingGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Looking for participantsNCT06514794What this trial is testingWU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)Who this might be right forT-cell Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma Allotera Therapeutics 125
Very early researchWithdrawnNCT04860817What this trial is testingAnti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBLWho this might be right forT-cell Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Early research (Phase 1)Study completedNCT01614197What this trial is testingA Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins LymphomaWho this might be right forLymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma Therapeutic Advances in Childhood Leukemia Consortium 16
Not applicableStudy completedNCT03098589What this trial is testingRevlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)Who this might be right forLymphoma Celgene 1,149
Testing effectiveness (Phase 2)Study completedNCT02955589What this trial is testingEfficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL)Who this might be right forAdult T-Cell Lymphoma (ATL) HUYABIO International, LLC. 23
Testing effectiveness (Phase 2)Ended earlyNCT00914940What this trial is testingSelective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHDWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)WithdrawnNCT06210750What this trial is testingAdding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)Who this might be right forT Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00036738What this trial is testingFludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blastic Phase+7 more Fred Hutchinson Cancer Center 28
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Not applicableStudy completedNCT06525116What this trial is testingMRD Detection by NGS in Pediatric T-ALLWho this might be right forAcute Lymphoblastic Leukemia, Pediatric The Children's Hospital of Zhejiang University School of Medicine 148
Early research (Phase 1)Study completedNCT01254578What this trial is testingLenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Large-scale testing (Phase 3)UnknownNCT00764907What this trial is testingRisk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia University Hospital, Motol 4,000
Not applicableLooking for participantsNCT06581081What this trial is testingBridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic LeukemiaWho this might be right forRelapsed Adult ALLB-cell Acute Lymphoblastic LeukemiaRefractory Acute Lymphoblastic Leukemia+1 more Peking University People's Hospital 130
Early research (Phase 1)Ended earlyNCT00004239What this trial is testing506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Alliance for Clinical Trials in Oncology 10